Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
warning letter
Pharma
Alembic site hit with warning letter on patient consent concerns
After a March inspection yielded a Form 483, Indian generics juggernaut Alembic has received a harsher reprimand from the FDA.
Fraiser Kansteiner
Jul 21, 2026 11:40am
Novo gets warning letter at site formerly owned by Catalent
Dec 16, 2025 10:14am
J&J subsidiary slapped with FDA warning letter
Sep 23, 2025 2:22pm
Granules hit with FDA warning letter over production woes
Mar 5, 2025 8:38am
Korea hits GSK for problems with asthma, acne drugs: report
Jul 30, 2024 9:20am
CDMO Brassica blasted in 4-observation FDA warning letter
Jul 24, 2024 9:25am
